Keyphrases
Nipah Virus
100%
Viral Budding
100%
Matrix Protein
100%
Ubiquitin
100%
Nucleocytoplasmic Transport
100%
Paramyxovirus
44%
Protease Inhibitors
33%
Plasma Membrane
22%
Nipah Virus Infection
22%
Nuclear Localization Signal
22%
Virus Budding
22%
Ubiquitination
11%
Lysine Residue
11%
Overexpression
11%
Encephalitis
11%
Age of Infection
11%
Biological Function
11%
FDA-approved Drugs
11%
Post-translational Modification
11%
Highly Pathogenic
11%
Viral Titer
11%
Structural Proteins
11%
Viral Assembly
11%
Dual Function
11%
Biosafety Level 4
11%
IC50
11%
Nuclear Localization
11%
Positive Charge
11%
Multiple Myeloma
11%
Free Ubiquitin
11%
Peak Plasma Concentration
11%
Nuclear Export
11%
Nuclear Retention
11%
Nuclear Import
11%
Nuclear Export Signal
11%
Matrix-based
11%
Leucine-rich
11%
Bortezomib
11%
Immunology and Microbiology
Virus Release
100%
Matrix Protein
100%
Nipah virus
100%
Ubiquitins
100%
Paramyxoviridae
36%
Proteasome
27%
Viral Disease
18%
Cell Membrane
18%
Nuclear Localization Signal
18%
Encephalitis
9%
Virus Assembly
9%
Infectious Agent
9%
Biological Functions
9%
Viral Load
9%
IC50
9%
Multiple Myeloma
9%
Nuclear Import
9%
Nuclear Export Signal
9%
Nuclear Export
9%
Maximum Plasma Concentration
9%
Lysine
9%
Post-Translational Modification
9%
Structural Protein
9%
Leucine
9%
Infection
9%